{"id":3359,"date":"2026-07-01T05:22:00","date_gmt":"2026-07-01T05:22:00","guid":{"rendered":"https:\/\/cielcharlotte.com\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/"},"modified":"2026-07-01T05:22:00","modified_gmt":"2026-07-01T05:22:00","slug":"mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe","status":"publish","type":"post","link":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/","title":{"rendered":"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe"},"content":{"rendered":"<p>GENEVA, Switzerland, July 1, 2026 \/PRNewswire\/ &#8212; MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced that the SwissNeuroRehab consortium has enrolled the first patients in a\u2026<\/p>\n<p><a href=\"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/in-hellonation-home-inspection-expert-luke-anglea-explains-what-inspectors-check-during-a-south-chicagoland-home-inspection-ai.jpglatest-news\/?prn_release=20260701LN96219\">Read the full release \u2192<\/a><\/p>\n<p><em>News provided by PR Newswire.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GENEVA, Switzerland, July 1, 2026 \/PRNewswire\/ &#8212; MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced that the SwissNeuroRehab consortium has enrolled the first patients in a\u2026<\/p>\n","protected":false},"author":14,"featured_media":3361,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-3359","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-art-community"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe - Ciel Charlotte<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe - Ciel Charlotte\" \/>\n<meta property=\"og:description\" content=\"GENEVA, Switzerland, July 1, 2026 \/PRNewswire\/ -- MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced that the SwissNeuroRehab consortium has enrolled the first patients in a\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"Ciel Charlotte\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-01T05:22:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe-ai.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ethan Parker\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ethan Parker\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/\"},\"author\":{\"name\":\"Ethan Parker\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#\\\/schema\\\/person\\\/4c5e38434c81d2ebb9c5787b29251450\"},\"headline\":\"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe\",\"datePublished\":\"2026-07-01T05:22:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/\"},\"wordCount\":59,\"image\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe-ai.png\",\"articleSection\":[\"Art Community\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/\",\"name\":\"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe - Ciel Charlotte\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe-ai.png\",\"datePublished\":\"2026-07-01T05:22:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#\\\/schema\\\/person\\\/4c5e38434c81d2ebb9c5787b29251450\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/#primaryimage\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe-ai.png\",\"contentUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe-ai.png\",\"width\":1536,\"height\":1024,\"caption\":\"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#website\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/\",\"name\":\"Ciel Charlotte\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#\\\/schema\\\/person\\\/4c5e38434c81d2ebb9c5787b29251450\",\"name\":\"Ethan Parker\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ethan-parkar-96x96.jpeg\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ethan-parkar-96x96.jpeg\",\"contentUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ethan-parkar-96x96.jpeg\",\"caption\":\"Ethan Parker\"},\"description\":\"Ethan Parker covers stories about community life, personal well-being, local initiatives, lifestyle trends, and the people working to create stronger communities. His writing looks for the human element behind larger developments, focusing on practical ideas and meaningful stories. Ethan brings an approachable perspective to subjects involving everyday life, community participation, creativity, and social connection.\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/author\\\/ethan-parker\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe - Ciel Charlotte","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe - Ciel Charlotte","og_description":"GENEVA, Switzerland, July 1, 2026 \/PRNewswire\/ -- MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced that the SwissNeuroRehab consortium has enrolled the first patients in a\u2026","og_url":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/","og_site_name":"Ciel Charlotte","article_published_time":"2026-07-01T05:22:00+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe-ai.png","type":"image\/png"}],"author":"Ethan Parker","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ethan Parker"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/#article","isPartOf":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/"},"author":{"name":"Ethan Parker","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#\/schema\/person\/4c5e38434c81d2ebb9c5787b29251450"},"headline":"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe","datePublished":"2026-07-01T05:22:00+00:00","mainEntityOfPage":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/"},"wordCount":59,"image":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe-ai.png","articleSection":["Art Community"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/","url":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/","name":"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe - Ciel Charlotte","isPartOf":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#website"},"primaryImageOfPage":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/#primaryimage"},"image":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe-ai.png","datePublished":"2026-07-01T05:22:00+00:00","author":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#\/schema\/person\/4c5e38434c81d2ebb9c5787b29251450"},"breadcrumb":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/#primaryimage","url":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe-ai.png","contentUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe-ai.png","width":1536,"height":1024,"caption":"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe"},{"@type":"BreadcrumbList","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/mindmaze-therapeutics-enrolls-first-patients-in-swissneurorehab-study-advancing-at-home-reimbursement-strategy-in-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/development.brstdev.com\/cielcharlotte\/"},{"@type":"ListItem","position":2,"name":"MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe"}]},{"@type":"WebSite","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#website","url":"https:\/\/development.brstdev.com\/cielcharlotte\/","name":"Ciel Charlotte","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/development.brstdev.com\/cielcharlotte\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#\/schema\/person\/4c5e38434c81d2ebb9c5787b29251450","name":"Ethan Parker","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/ethan-parkar-96x96.jpeg","url":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/ethan-parkar-96x96.jpeg","contentUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/ethan-parkar-96x96.jpeg","caption":"Ethan Parker"},"description":"Ethan Parker covers stories about community life, personal well-being, local initiatives, lifestyle trends, and the people working to create stronger communities. His writing looks for the human element behind larger developments, focusing on practical ideas and meaningful stories. Ethan brings an approachable perspective to subjects involving everyday life, community participation, creativity, and social connection.","url":"https:\/\/development.brstdev.com\/cielcharlotte\/author\/ethan-parker\/"}]}},"_links":{"self":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts\/3359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/comments?post=3359"}],"version-history":[{"count":1,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts\/3359\/revisions"}],"predecessor-version":[{"id":9112,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts\/3359\/revisions\/9112"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/media\/3361"}],"wp:attachment":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/media?parent=3359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/categories?post=3359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/tags?post=3359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}